(Q48581887)

13 February 2018

title

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. (English)

1 reference

13 February 2018

1 reference

5

John Q Trojanowski

1 reference

13 February 2018

author name string

Benoit I Giasson

1

1 reference

13 February 2018

John E Duda

2

1 reference

13 February 2018

Shawn M Quinn

3

1 reference

13 February 2018

Bin Zhang

4

1 reference

13 February 2018

Virginia M-Y Lee

6

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

13 February 2018

published in

Neuron

1 reference

13 February 2018

volume

34

1 reference

13 February 2018

page(s)

521-533

1 reference

13 February 2018

issue

4

1 reference

13 February 2018

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

A vector for expressing foreign genes in the brains and hearts of transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Widespread alterations of alpha-synuclein in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Neuropathology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Alpha-synuclein and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Clinical genetic analysis of Parkinson's disease in the Contursi kindred

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Neurofilaments in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Neuronal intermediate filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Comparison of modified Bielschowsky silver impregnation and anti‐ubiquitin immunostaining of cortical and nigral Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Induction of alpha-synuclein aggregation by intracellular nitrative insult.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Standardization of various applications of methacrylate embedding and silver methenamine for light and electron microscopy immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr ?-synuclein mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Distribution of tau proteins in the normal human central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Neuropathology in mice expressing human alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900682-7

7 January 2021

10.1016/S0896-6273(02)00682-7

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

12062037

1 reference

13 February 2018